Studying the Immune Response to COVID-19
The NCI-sponsored Serological Sciences Network (SeroNet) is the nation’s largest coordinated effort to study COVID-19.
One of eight national SeroNet Centers of Excellence, Stanford SeroNet is part of the nation’s largest coordinated effort to study the immune response to COVID-19. SeroNet is comprised of a national network of U54 Centers of Excellence, U01 project grants, and Capacity Building Centers that collaborate with the Frederick National Laboratory for Cancer Research and the SeroNet Coordinating Center to combat the COVID-19 pandemic.
The network aims to combat the pandemic by improving the ability to test for infection, especially among diverse populations, and speed the development of treatments and vaccines.
Study links severe COVID-19 to increase in self-attacking antibodies
A study spearheaded by Stanford researchers indicates that at least 1 in 5 hospitalized COVID-19 patients develops new antibodies that attack their own tissue within a week of admission.
- – News Center
Study shows why second dose of COVID-19 vaccine shouldn’t be skipped
Scientists scrutinized Pfizer vaccine recipients’ blood samples to learn exactly what effects the vaccine exerts on the body’s immune system.
- – Nature
Systems vaccinology of the Pfizer-BioNTech mRNA vaccine in humans
Profiling the immune responses of 56 healthy volunteers vaccinated with BNT162b2 reveals how this mRNA vaccine primes the innate immune system to mount a potent response to SARS-CoV-2 after booster immunization.
- – Science
Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
Blood taken from children before the COVID-19 pandemic contains memory B cells that bind SARS-CoV-2.
- – Blood Plasma Reduces Risk of Severe Covid
Blood Plasma Reduces Risk of Severe Covid-19 if Given Early
Thousands of people received convalescent plasma as an experimental treatment for Covid. A new study shows that it works — but only when given within a few days of the onset of illness.
- – News Center
Stanford Medicine COVID-19 test now in use
The Stanford Clinical Virology Laboratory has deployed an in-house diagnostic test for the virus that causes COVID-19. Rapid identification of infected people could help limit the spread of the virus.